Infectious disease physicians, infectious disease pharmacists, critical care specialists, pharmacy/formulary directors, and other providers who treat and/or monitor patients with hospital- or ventilator-acquired pneumonias (eg, clinical pharmacists, clinical microbiologists, hospitalists)
After completing this activity, participants should be better able to:
- Review the diagnostic approach and pathophysiology of hospital- and ventilator-acquired bacterial pneumonia.
- Describe the health and economic burden of hospital- and ventilator-acquired pneumonia.
- Explain the major mechanisms of resistance seen in nosocomial pneumonias.
- Develop an optimal treatment plan incorporating novel therapies for patients with hospital- or ventilator-acquired bacterial pneumonia including those with antibiotic resistance.